Semigran Marc

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Semigran Marc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Development Officer Restricted Stock Units 23.1K $437K $18.91 12 Aug 2024 Direct
Edgewise Therapeutics, Inc. Chief Development Officer Common Stock 6.72K $202K $30.08 24 Dec 2024 Direct
Edgewise Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 270K 24 Dec 2024 Direct
Renovacor, Inc. Chief Medical Officer Common Stock 0 $8.00 01 Dec 2022 Direct
Renovacor, Inc. Chief Medical Officer Stock Option 0 01 Dec 2022 Direct

Insider Reports Filed by Semigran Marc

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 24 Dec 2024 4 -$616K 4 Chief Development Officer 27 Dec 2024, 16:30
EWTX Edgewise Therapeutics, Inc. 12 Aug 2024 2 $0 4 Chief Development Officer 14 Aug 2024, 16:15
EWTX Edgewise Therapeutics, Inc. 17 Aug 2023 1 $0 4 Chief Development Officer 18 Aug 2023, 19:13
EWTX Edgewise Therapeutics, Inc. 30 Dec 2022 1 $0 4 Chief Development Officer 03 Jan 2023, 15:44
EWTX Edgewise Therapeutics, Inc. 19 Dec 2022 0 $0 3 Chief Development Officer 22 Dec 2022, 15:04
RCOR Renovacor, Inc. 01 Dec 2022 6 $0 4 Chief Medical Officer 05 Dec 2022, 20:21
RCOR Renovacor, Inc. 24 Jan 2022 2 $0 4 Chief Medical Officer 26 Jan 2022, 17:30
RCOR Renovacor, Inc. 20 Dec 2021 1 $0 4 Chief Medical Officer 22 Dec 2021, 15:30
RCOR Renovacor, Inc. 03 Sep 2021 1 $0 4 Chief Medical Officer 08 Sep 2021, 18:59
RCOR Renovacor, Inc. 02 Sep 2021 0 $0 3 Chief Medical Officer 07 Sep 2021, 21:30
PROK Social Capital Suvretta Holdings Corp. III 29 Jun 2021 0 $0 3 Director 29 Jun 2021, 20:09